RHEA Generics Partners with Fresenius Kabi to launch new generic medicine addressing chronic kidney disease
RHEA
Generics, a frontrunner of world-class and affordable medicines in the country,
recently formalized its partnership with global healthcare company Fresenius
Kabi, which will launch a new generic medicine addressing chronic kidney
disease in the Philippines.
According
to the National Kidney and Transplant Institute, over 10,800 Filipinos are
affected by chronic kidney disease, with tens of thousands of patients needing
to undergo dialysis annually.
Philusa
Corporation President and General Manager Neogin Evangelista expressed, “Our latest
collaboration with Fresenius Kabi affirms our ceaseless pledge in deliveringexcellent
quality medicines catering to a diverse set of medical concernsthat is
economically, and conveniently accessible to our fellow Filipinos. RHEA
Generics will continue to work hand in hand with leading global pharmaceutical
companies to ensure we are able to deliver our promise of offering generic
medicines having the same quality, efficacy and safety of the innovator brands.”
The
newRHEA Generics drug, which will be exclusively available in all Mercury Drug
stores nationwide starting November, in combination with a protein-restricted
diet is an excellent drug that preserves the residual function of the kidneys
of patients with Chronic Kidney Disease and delays its progression to dialysis.
0 comments